Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 3/20 | 0.43 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.43 |
| ▸ | FEN1 | P39748 | 2/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.42 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27716203 | 0.85 | NCOA1 (0.62) | SCN9ATSHRARNCOA1NCOA3 | |
| SCHEMBL1436484 | 0.85 | FYN (0.56) | ARFYNMAOBSTAT3 | |
| SCHEMBL31463164 | 0.83 | TSHR (0.57) | TSHRMMP3PTGS1MAOB | |
| SCHEMBL28421503 | 0.82 | SCN9A (0.51) | SCN9AARALOX5APFEN1NCOA1 | |
| SCHEMBL31501815 | 0.80 | MMP3 (0.40) | SCN9ATSHRARFYNMMP3 | |
| SCHEMBL4599915 | 0.80 | FFAR4 (0.50) | SCN9AARALOX5APFEN1 | |
| SCHEMBL7038780 | 0.80 | NCOA1 (0.42) | SCN9AARALOX5APFEN1NCOA1 | |
| SCHEMBL5872097 | 0.80 | APP (0.48) | SCN9AARNCOA1NCOA3 | |
| SCHEMBL9422296 | 0.80 | SLC6A4 (0.57) | TSHRARNCOA1NCOA3SLC6A4 | |
| Hydrochloric Acid SCHEMBL4599483 | 0.79 | FFAR4 (0.49) | SCN9AARALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295490-A1 | LIGHT-EMITTING NANOPARTICLES AND LIGHT-EMITTING LABELING MATERIAL FOR PATHOLOGICAL DIAGNOSIS | Konica Minolta, Inc. (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230295490-A1 | LIGHT-EMITTING NANOPARTICLES AND LIGHT-EMITTING LABELING MATERIAL FOR PATHOLOGICAL DIAGNOSIS | Konica Minolta, Inc. (JP) | 2023-09-21 | — | — | US | disclosed |
| US-11329234-B2 | Organic electroluminescent element, display device, lighting device, π-conjugated compound, and light-emitting thin film | MERCK PATENT GMBH (DE) | 2022-05-10 | — | — | US | disclosed |
| WO-2021261398-A1 | LIGHT-EMITTING NANOPARTICLES AND LIGHT-EMITTING LABELING MATERIAL FOR PATHOLOGICAL DIAGNOSIS | コニカミノルタ株式会社 | 2021-12-30 | — | — | WO | disclosed |
| US-10950799-B2 | Organic electroluminescent element, display device, lighting device, PI-conjugated compound, and light-emitting thin film | MERCK PATENT GMBH (DE) | 2021-03-16 | — | — | US | disclosed |
| US-20200044164-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM | UDC IRELAND LIMITED (IE) | 2020-02-06 | — | — | US | disclosed |
| US-20170271597-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM | MERCK PATENT GMBH (DE) | 2017-09-21 | — | — | US | disclosed |
| US-20170271597-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM | MERCK PATENT GMBH (DE) | 2017-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200044164-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM | LPO, L1CAM, INTS9 | SCN9A 684/4885TSHR 4392/4885AR 3974/4885 |
| US-10950799-B2 | Organic electroluminescent element, display device, lighting device, PI-conjugated compound, and light-emitting thin film | LPO, L1CAM, INTS9 | SCN9A 684/4885TSHR 4392/4885AR 3974/4885 |
| US-20170271597-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM | LPO, L1CAM, INTS9 | SCN9A 394/4885TSHR 4454/4885AR 3993/4885 |
| US-11329234-B2 | Organic electroluminescent element, display device, lighting device, π-conjugated compound, and light-emitting thin film | LPO, L1CAM, SELE | SCN9A 544/4885TSHR 4231/4885AR 3690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.